Clinical Trial Update: Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 pilot trial evaluating cardiac resynchronization therapy in patients with atrial fibrillation and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Atrial Fibrillation, Heart Failure | Phase 4 | Status: UNKNOWN